We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Gab4.0
GABA Research
Mostly mechanism / observational
44 peer-reviewed studies
What the evidence says
Likely helps
GABA appears to help in 3 of 3 studies with measurable effects — the evidence leans clearly favourable.
Most evidence is from high-quality meta-analyses and randomised trials published 1976–2026 with a typical study size of 90 participants.
Based on 43 studies · 1 meta-analysis · 25 RCTs · 1,548 total participants
Confidence
High confidence
What the studies found
3helped· 40 more without graded effect data
By outcome
Therapeutic & clinical
Mostly mechanism / observational10 studies
Sleep & insomniaMay reduce time to fall asleep · 30-60 minutes · GABAergic activity promotes deeper, more restorative sleep stages · 1-2 weeks · Inhibitory neurotransmitter support may improve sleep continuity · 1-2 weeks
Mostly mechanism / observational9 studies
Anxiety & stressReduced acute anxiety and stress · 30-60 minutes
Mostly mechanism / observational8 studies
Safety profile
Mostly mechanism / observational6 studies
Depression & moodCalming effects support emotional regulation · 2-4 weeks
Mostly mechanism / observational5 studies
Neuroprotection & brain aging
Mostly mechanism / observational5 studies
Heart & blood pressure
Mostly mechanism / observational5 studies
Cognitive function
Mostly mechanism / observational4 studies
By the numbers
Pulled from 11 studies with measurable effects
Likely real effects
100%
across studies
People studied
1,548
typical study: 90 people
Strongest designs
26
1 pooled, 25 randomised
Showed benefit
100%
3/3 studies
How long studies ran
1–4 weeks
1
Populations Studied
Patients with insomnia1
Mild cognitive impairment and Alzheimer's disease patients1
Adults1
Children and adolescents with ASD and/or ADHD1
Active research area
28 studies in the last 5 years · Latest meta-analysis: 2024
197620012026
1Systematic Reviewn=470 · medium study2020
In plain English: Oral GABA supplementation showed benefits for stress reduction and sleep quality across reviewed clinical trials.
Hepsomali P et al. · Nutrients (2020)
GABA supplementation reduced subjective stress markers within 30-60 minutes
Sleep quality improvements observed at doses of 100-300mg
Mechanism of action likely involves gut-brain axis signaling rather than direct BBB crossing
2Herbal remedies effect on GABAergic system and sleepSystematic Review2021
In plain English: Currently available evidence suggests that herbal extracts may exert some of their hypnotic and anxiolytic activity through interacting with GABA receptors and modulating GABAergic signaling in the brain, but their mechanism of action in the treatment of insomnia is not completely understood.
Bruni O et al. · Nutrients (2021)
Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states.
GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines.
Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control.
3Cognitive function and gut microbiome compositionReview2026
In plain English: This review describes the role of the gut microbiome and probiotics in AD.
Ajith TA et al. · Nutritional neuroscience (2026)
Compared to healthy controls, mild cognitive impairment and AD were associated with low levels of Firmicutes and Bifidobacterium and high levels of Proteobacteria and Bacteroidetes.
Lactobacillus and Bifidobacterium species were effective in improving cognitive function.
More longitudinal research is needed to investigate precision medicine in patients with dysbiosis in the preclinical stages of the disease.
In plain English: A better understanding of GABA may introduce new windows for its application in developing functional foods.
Hou D et al. · Critical reviews in food science and nutrition (2024)
Herein, this review provides a comprehensive insight on the dietary sources, enrichment technologies, processing effects of GABA, and its applications in food industry.
Furthermore, the various health benefits of GABA-enriched foods, mainly including neuroprotection, anti-insomnia, anti-depression, anti-hypertensive, anti-diabetes, and anti-inflammatory are also summarized.
The main challenges for future research on GABA are related to exploring high GABA producing strains, enhancing the stability of GABA during storage, and developing emerging enrichment technologies without affecting food quality and other active ingredients.
In plain English: GABA supplementation elicited noteworthy enhancements in heart rate variability, emotional response, depression mitigation, and sleep efficiency following a 90-day supplementation.
Guimarães AP et al. · Journal of dietary supplements (2024)
Moreover, an improved emotional response was observed, characterized by diminished negative affect.
GABA supplementation yielded ameliorations in depression scores as per the Depression, Anxiety, and Stress Scale (DASS-21).
Notably, an augmented HRV was noted, attributed to heightened parasympathetic autonomic nervous system predominance.
In plain English: Adds direct RCT evidence for GABA's effect on sleep onset and quality in clinically defined insomnia, strengthening the mechanistic case for supplementation.
Yamatsu A et al. · Nutrients (2024)
GABA supplementation significantly reduced sleep onset latency compared to placebo
Significant improvements in overall Pittsburgh Sleep Quality Index scores in the GABA group
Subjective sleep satisfaction was higher in the treatment arm with no adverse events
In plain English: Provides recent RCT-level evidence for oral GABA supplementation improving clinically relevant sleep outcomes in adults with insomnia.
Hepsomali P et al. · Frontiers in Neuroscience (2024)
Significant reduction in sleep onset latency in the GABA group versus placebo
Improved Pittsburgh Sleep Quality Index scores after 4 weeks of supplementation
GABA supplementation was safe and well-tolerated throughout the trial
20Symptomatology of autism spectrum disorder and ADHDRCTn=80 · small study2025
In plain English: The probiotics used, may improve hyperactivity-impulsivity in children with ASD or/and ADHD and quality of life in children with ASD.
Rojo-Marticella M et al. · Research on child and adolescent psychopathology (2025)
Noticeable benefit
← WorseNo effectBetter →
Likely real
A better comfort score (quality of life) was shown in children with ASD (probiotic: p = 0.010, Cohen's d = 0.722; placebo: p = 0.099, Cohen's d = 0.456).
The probiotics used, may improve hyperactivity-impulsivity in children with ASD or/and ADHD and quality of life in children with ASD.